Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
February 1, 2023

Mindpeak's PD-L1: First AI to be used in labs in Belgium to fight cancer

Mindpeak's PD-L1: First AI to be used in labs in Belgium to fight cancer

Ziekenhuis Netwerk Antwerpen (ZNA) and GZA Hospitals chose Mindpeak’s PD-L1 AI  to become the first lab in Belgium to use artificial intelligence in the fight against cancer.

Deeply integrated into the Telemis-platform, our AI helps their pathologists diagnose patients quicker and more reproducible by considering the complete tissue on images from biopsies and resectates - especially from the lung (PD-L1).

"With our AI, the matching of cancer patients to drugs can be significantly improved in clinical routine, which in turn greatly increases the chances of cure," says our founder and CEO Felix Faber.

Source

You may also be interested in

April 17, 2023
Mindpeak's HER2 low comes out on top in comparative study by Cypath

In a first of its kind comparative study, Mindpeak's CE-marked HER2 AI for breast cancer diagnosis was compared to three other commercial AIs (e.g. Visiopharm). Mindpeak's AI showed the highest accuracy of all AIs in terms of balanced clinical scores (88.1%) for HER2-low, higher than the score of the next best AI (67.3%) and higher than the concordance of pathologists with the reference score (85.5%).

Read more ⟶
February 1, 2023
Mindpeak's PD-L1: First AI to be used in labs in Belgium to fight cancer

Ziekenhuis Netwerk Antwerpen (ZNA) and GZA Hospitals chose Mindpeak’s PD-L1 AI to become the first lab in Belgium to use artificial intelligence in the fight against cancer.

Read more ⟶
September 29, 2022
Top marks for Mindpeak's latest lung cancer diagnosis software

Mindpeak scores successfully in new digital quality test (Digital Readout Test) by leading German pathology quality assurance service provider QuIP

Read more ⟶

Find out more about our AI-based diagnostics

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mindpeak Breast IHC being displayed on a monitor

About Mindpeak

We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses.
‍
This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable. Explainable AI (xAI) results provide the required trust of pathologists into our tools.

Company information

Local court Hamburg HRB 151143
‍
Managing directors:
Felix Faber, Dr. Tobias Lang
‍
V.A.T. identification number:
DE318495606

Founded in 2018
‍

Contact us

Mindpeak GmbH
Zirkusweg 2
20359 Hamburg
Germany
Email: info@mindpeak.ai
Telephone: +49 40 35 67 67 97

Regulatory Note:
Unless otherwise stated all products are intended for Research Use Only, not for use in diagnostic procedures.

© 2022 Mindpeak GmbH

Supported by:

Horizon 2020 (European Commission)

Privacy policy

Contact